The Duke Clinical Research Institute Director of Health Services and Outcomes Research and Co-Principal Investigator for the PCORnet Coordinating Center Adrian Hernandez, MD, MHS, was recently invited to participate in a Bipartisan Policy Center (BPC) roundtable focused on advancing the generation and use of real-world evidence.
The BPC, a nonprofit organization devoted to bipartisan solutions to questions of public policy, hosted the meeting at its headquarters in Washington, D.C. on June 23.
At the crux of the discussion was a new report issued by the BPC entitled Using Real World Evidence to Accelerate Safe and Effective Cures. The report expands on the recommendations in BPC’s July 2015 report, Advancing Medical Innovation for a Healthier America, and proposes four key recommendations for modernizing the drug development process through the use of real-world evidence.
Hernandez noted that PCORnet is one the most robust endeavors to promote the use of real-world data to date.
“With electronic health record and other clinical- and patient-reported data from more than 100,000,000 persons, PCORnet provides a model for the use of real-world evidence to accelerate the nation’s capacity to conduct patient-centered clinical research—including pragmatic clinical trials to generate answers more efficiently,” he said. “This roundtable was an opportunity to emphasize the pressing need for regulatory guidance and policies that will facilitate the use of PCORnet and other tools to bring real-world data to life.”
Read more about Hernandez’s insights from the roundtable and the BPC report calls for actions to modernize the drug development process through the use of real-world evidence.